Sport gives familiar words a separate job.
Approved, prohibited, monitored: these words do different jobs. I keep them apart so a sport rule doesn’t get mistaken for a medical opinion. The organisation and year matter as much as the substance’s name.
Prohibition
On October 27, 2026, the World Anti-Doping Agency’s 2026 Prohibited List is in force. It names BPC-157 in S0, its category for non-approved substances. That prohibition applies during and outside competition, including ordinary training.
S0 covers substances with no government approval anywhere for human treatment, unless another part of the list addresses them. Approval somewhere can affect that test. It doesn’t mean every other sport rule has been met. I keep the full definition within reach rather than guessing from a name.
The medical question remains separate. FDA’s BPC-157 review describes limited human studies that can’t establish safety or support broad healing claims. Some of the healing talk comes from studies of injured Achilles tendons in rodents. Those are animal findings, not proof of healing in people. Knowing which sport category a peptide falls into doesn’t tell you what it will do to a person.
Monitoring gives us a different word to explain.
Monitoring
Semaglutide isn’t on WADA’s 2026 Prohibited List. Instead, WADA monitors its use, as the 2026 explanatory notes describe. Monitoring means watching patterns of use for substances outside the prohibited list. It isn’t a ban or a medical clearance.
That distinction matters even when two documents look similar. Semaglutide’s label still includes stomach side effects and serious warnings. Appearing on a watch list, or being absent from a banned list, doesn’t answer those medical questions. A future year can also bring different sport rules.
WADA’s 2027 Prohibited List takes effect January 1, 2027. It adds peptides as examples within S0’s existing approval test; it doesn’t ban every peptide medicine. The separate 2027 Monitoring Program names semaglutide and tirzepatide. Published and in force are different dates.
The next detail is whose list you’re reading.
Jurisdiction
Jurisdiction means whose rules apply. American college sport uses the 2026–27 NCAA banned-substances list. It names BPC-157 under peptide hormones and related substances, while WADA puts it in S0. I name the organisation so those classifications don’t get muddled.
A prescription doesn’t automatically override a sport prohibition. USADA explains its therapeutic use exemption process, which concerns medical permission under specific sport rules. It has its own requirements. It isn’t general permission to use an unapproved peptide.
For an athlete’s individual question, the governing body can identify the rules and a licensed clinician can address the medical situation. I keep the documents together on the references page. The exact substance, organisation and year need to stay together too.
The organisation and date finish the rule’s description.